BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit

May 21, 2021

BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System

May 4, 2021

BioSig Technologies, Inc. Invited to Present at Wall Street Conference

May 3, 2021

BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona

April 27, 2021

BioSig Expands Commercial Team in Two Strategic Regions

April 15, 2021

BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform

April 14, 2021

BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study

April 13, 2021

BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)

April 9, 2021

EP Lab Digest Features Physician Experience with BioSig’s Cardiac Signal Acquisition Technology

April 8, 2021

BioSig lands Commercial Sales to Leading Hospital System

April 6, 2021